Digital Diabetes Management Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Digital Diabetes Management Market size was worth USD 18.9 billion in 2022. Driven by the rising prevalence of diabetes globally, the industry could grow at 20% CAGR from 2023 to 2032.
Growing adoption of a sedentary lifestyle, poor eating habits, and rising cases of obesity have increased the occurrence of diabetes, increasing the demand for digital diabetes management for remote patient monitoring. As per the International Diabetes Federation, in 2021, the global diabetes prevalence in people aged between 20 to 79 years was 10.5% (536.6 million people), which is projected to reach around 783 million people by 2045.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Digital Diabetes Management Market Size in 2022: | USD 18.9 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 20.0 |
2023 Value Projection: | USD 117.8 Billion |
Historical Data for: | 2018 to 2022 |
No of Pages: | 260 |
Tables, Charts & Figures: | 366 |
Segments Covered: | Product Type, Patient Type, End-use and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The COVID-19 pandemic asserted a profound impact on the digital diabetes management market. The high susceptibility of diabetes patients to COVID1-9 infection increased the demand for remote patient monitoring devices for continued disease monitoring. Many government authorities across the globe also granted emergency use authorization for diabetes care devices. For instance, the U.S. FDA rolled out the guidance for permitting home-based blood glucose meters in hospitals. Such initiatives further helped strengthen the market outlook during the crisis.
The advent of big data analytics and AI in diabetes devices will create ample opportunities for the market. AI technology has gained immense traction in insulin monitoring, insulin injection guidance, diabetes prediction, and exercise guidance in diabetes management. Moreover, a remarkable growth in AI technology is helping healthcare providers get access to large data sets of diabetes patients. This high availability of information is helping patients get customized treatment for enhanced clinical outcomes thus, stimulating industry revenue streams.
Based on product, Digital diabetes management market share from the services segment will grow at over 18.5% CAGR from 2023 to 2032. Rapid advancements in diabetes management apps and software will present new pathways for segment growth. Some diabetes management apps can now integrate fitness trackers and wearable medical devices, such as smartwatches and activity monitors. This integration allows individuals to track their physical activity levels, monitor their heart rate, and estimate the impact of exercise on their blood sugar levels.
With respect to end-use, the digital diabetes management market size from the hospitals segment reached over USD 7 billion in 2022. Growing usage of digital technologies for remote patient monitoring in hospitals will contribute to segment growth. Moreover, the high availability of advanced digital diabetes management tools, such as insulin delivery devices, has increased patient visits to these facilities. Many governments across the globe also granted approval for a few digital diabetes management products in hospitals during COVID-19, thereby augmenting segment gains.
On the regional front, North America digital diabetes management market will grow at over 19% CAGR between 2023 and 2032. Growing prevalence of diabetes has increased the need for diabetes care devices in the region. Supportive government initiatives for the treatment of the disease are creating a favorable growth outlook for the regional industry. In fact, in November 2021, the government of Canada and partners announced an investment of USD 20 million in new diabetes research teams for the treatment of people living with diabetes.
Market Size, By Product
Market Size, By Patient
Market Size, By End-use
The above information is provided for the following regions and countries:
In 2022, the digital diabetes management industry was valued at USD 18.9 billion and will grow at 20% CAGR from 2023 to 2032, attributed to the growing prevalence of diabetes globally.
The market share from the services segment will grow at more than 18.5% CAGR from 2023 to 2032, owing to rapid advancements in diabetes management software and apps.
North America digital diabetes management market size reached over USD 6 billion in 2022, attributed to the favorable government initiatives for diabetes treatment.
Major digital diabetes management industry players include Abbott Laboratories, F.Hoffmann-La Roche Ltd, Senseonics, Tandem Diabetes Care, Inc, Medtronic Plc, Dexcom, Inc, and Insulet Corporation, among others.